Good day to all.
It would seem that there are many here with short memory or short shares, whatever the case might be, please allow me to refresh your memory (I am an investor and not a trader, so if you are a short-term person please just disregards this):
We have a successful M-M trial. Not telling if we will be given EUA (we should) or will need to initialize confirmatory P3 for moderate patients. This should be relatively fast (imo around 100 patients).
Additionally we will have a successful S-C trial (the M-M was the harbinger of what we will get) very soon. If anything, we need to accelerate enrolling. We have 9 centers currently recruiting:
UCLA, California
Beth Israel Deaconess Medical Center. Massachussettes
St. Barnabas. New Jersey
Atlantic Health System Hospital, New Jersey
Montefiore Medical Center, New York
Novant Health, North Carolina
Ohio Health, Ohio
Baylor Scott & White research Institute. Texas
University of Texas, Texas
We should be able to complete 20 more patents shortly, get ready for our interim and BOOM !!!
The recent stock price behavior is irrational, but, when has it been rational?? For us old timers, this is déjà vu. I remember vividly the months previous to December 2019, however, thanks to the Russian announcement (that does not mean much as they are in “equivalent” P1) the entire COVID space was decimated.
We are doing well and will do very well.
Unfortunately, COVID is not going anywhere for the time being. Also, as Dr. Paterson mentioned the world need to stockpile Leronlimab !!!. Once FDA is "happy" in that Leronlimab works we will be playing in the big leagues (I am talking SP here). This will happen for M-M and S-C. It might happen soon (EUA) or latter, but will happen.
The up listing is a reality and we will get a nice surprise (and price raise) in the near future not to mention a sharp increase in average volume and institutional investors coming onboard. The “age” of single digit SP will be a memory.
So, calm down if you are an investor (and not a trader), grab some coffee and bid your time. We will get there as we are walking the walk.
It would seem that there are many here with short memory or short shares, whatever the case might be, please allow me to refresh your memory (I am an investor and not a trader, so if you are a short-term person please just disregards this):
We have a successful M-M trial. Not telling if we will be given EUA (we should) or will need to initialize confirmatory P3 for moderate patients. This should be relatively fast (imo around 100 patients).
Additionally we will have a successful S-C trial (the M-M was the harbinger of what we will get) very soon. If anything, we need to accelerate enrolling. We have 9 centers currently recruiting:
UCLA, California
Beth Israel Deaconess Medical Center. Massachussettes
St. Barnabas. New Jersey
Atlantic Health System Hospital, New Jersey
Montefiore Medical Center, New York
Novant Health, North Carolina
Ohio Health, Ohio
Baylor Scott & White research Institute. Texas
University of Texas, Texas
We should be able to complete 20 more patents shortly, get ready for our interim and BOOM !!!
The recent stock price behavior is irrational, but, when has it been rational?? For us old timers, this is déjà vu. I remember vividly the months previous to December 2019, however, thanks to the Russian announcement (that does not mean much as they are in “equivalent” P1) the entire COVID space was decimated.
We are doing well and will do very well.
Unfortunately, COVID is not going anywhere for the time being. Also, as Dr. Paterson mentioned the world need to stockpile Leronlimab !!!. Once FDA is "happy" in that Leronlimab works we will be playing in the big leagues (I am talking SP here). This will happen for M-M and S-C. It might happen soon (EUA) or latter, but will happen.
The up listing is a reality and we will get a nice surprise (and price raise) in the near future not to mention a sharp increase in average volume and institutional investors coming onboard. The “age” of single digit SP will be a memory.
So, calm down if you are an investor (and not a trader), grab some coffee and bid your time. We will get there as we are walking the walk.
25
